MPAM
AGN

Murphy Pohlad Asset Management’s Allergan plc AGN Stock Holding History

Murphy Pohlad Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,346
Closed -$628K – 100
2016
Q1 		$628K Buy
+2,346
New +$672K 0.47% 65

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Murphy Pohlad Asset Management's AGN Position: Q2 2016 in Review

Murphy Pohlad Asset Management sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 2,346 shares — an estimated $628K sold.

Murphy Pohlad Asset Management first reported a position in AGN in Q1 2016 and held it in 1 quarter. The position peaked at $628K in Q1 2016. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Murphy Pohlad Asset Management reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Murphy Pohlad Asset Management sold 2,346 Allergan plc shares in Q2 2016, an estimated $628K.
  • Murphy Pohlad Asset Management first reported a position in Allergan plc in Q1 2016 and held it in 1 quarter.
  • Murphy Pohlad Asset Management's Allergan plc position peaked at $628K in Q1 2016.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Murphy Pohlad Asset Management's 13F filing for Q2 2016, filed 13 Jul 2016.